Company

Smart Assays caters to start-ups with limited in-house R&D resources that need to develop core assets, including PoC studies, to attract the next investment round, or for VCs looking to decrease investment risks in their due diligence process by tapping into objective scientific expertise.

The services of Smart Assays reflect the company's unique work model – a combination of proficiency in analytical chemistry and biochemical processes, provided by a skilled team capable of thinking out of the box and with extensive cumulative scientific knowledge and a proven track record in assay development, drug discovery, MoA studies, research histopathology and bioanalytic research. The Smart Assays FTE program offers a PhD-level scientist fully dedicated to a client’s project.

Smart Assays was established in 2005 and is situated in the Weizmann Science Park in the heart of Israel’s entrepreneurial Life Science and Biotech ecosystem.